Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Receipt Of Manufacturing License For Biomescan Analytics Platform
Filed with BSE · · 2 pages · English
The licence has been granted under the Medical Devices Rules, 2017, marking a significant milestone in bringing gut microbiome science into mainstream wellness and preventive healthcare. Key details regarding the development are outlined below: • Platform Overview: Biomescan combines whole metagenome sequencing data with a validated bioinformatics pipeline to generate detailed gut microbiome profi
Lord's Mark Industries Limited on 6ix
Earlier from Lord's Mark Industries
- Resignation Of Secretarial Auditor
- Clarification To Shareholders And Investors Regarding Trading Status Of Equity Shares Under "Trading Restricted - On Account Of IRP As Per IBC / Recommencement Post IBC - IRP Stage-1"
- Announcement under Regulation 30 (LODR)-Allotment
- Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And DisclosureRequirements) Regulations, 2015 - Update In Continuation Of Disclosure Dated 08 June 2026 Regarding Initiation Of Process For Listing And Trading Of Equity Shares Issued To
Later from Lord's Mark Industries
- Board Meeting Outcome for Outcome Of Board Meeting Held On 13 August 2026
- Financial Results For Quarter Ended On 30Th June 2026
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Business And Strategic Updates
- AGM And Important Dates
- News Paper Publishment
Follow Lord's Mark Industries into a list and get an email when it puts out news.
Follow Lord's Mark Industries